High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case Report
Objective: To present a case of high-risk, stage four neuroblastoma in a 20-year-old woman who survived more than 21 months with the multimodal therapy. Methods: A case of high-risk, stage four neuroblastoma in a 20-year-old woman who survived more than 21 months with multimodal therapy is reported...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Padjadjaran
2022-09-01
|
| Series: | International Journal of Integrated Health Sciences |
| Subjects: | |
| Online Access: | https://journal.fk.unpad.ac.id/index.php/ijihs/article/view/2868 |
| _version_ | 1828034729309372416 |
|---|---|
| author | Amaylia Oehadian Afiati Afiati Martina Sung Kevin Yonatan Budiman Fransisca Fransisca |
| author_facet | Amaylia Oehadian Afiati Afiati Martina Sung Kevin Yonatan Budiman Fransisca Fransisca |
| author_sort | Amaylia Oehadian |
| collection | DOAJ |
| description | Objective: To present a case of high-risk, stage four neuroblastoma in a 20-year-old woman who survived more than 21 months with the multimodal therapy.
Methods: A case of high-risk, stage four neuroblastoma in a 20-year-old woman who survived more than 21 months with multimodal therapy is reported. The patient initially received neoadjuvant chemotherapy according to the Turkish Pediatric Oncology Group of Neuroblastoma, along with multiple doses of radiotherapy. After two cycles of induction chemotherapy, she successfully underwent tumor debulking surgery.
Results: With the multimodal therapy, patient remains in complete remission state and stable disease of the remaining lesions is observed in this patient.
Conclusions: Neuroblastoma is a rare disease in adults and associated with a high number of mortality. Early and accurate diagnosis and multimodality of treatments are important to achieve disease control. Long term follow up is necessary for such patients. |
| first_indexed | 2024-04-10T15:37:48Z |
| format | Article |
| id | doaj.art-750d65d43e454154959a58111fcca4ca |
| institution | Directory Open Access Journal |
| issn | 2302-1381 2338-4506 |
| language | English |
| last_indexed | 2024-04-10T15:37:48Z |
| publishDate | 2022-09-01 |
| publisher | Universitas Padjadjaran |
| record_format | Article |
| series | International Journal of Integrated Health Sciences |
| spelling | doaj.art-750d65d43e454154959a58111fcca4ca2023-02-13T02:55:07ZengUniversitas PadjadjaranInternational Journal of Integrated Health Sciences2302-13812338-45062022-09-0110210210610.15850/ijihs.v10n2.28681507High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case ReportAmaylia Oehadian0Afiati Afiati1Martina Sung2Kevin Yonatan Budiman3Fransisca Fransisca4Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, BandungDepartment of Pathology Anatomy, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, BandungDepartment of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, BandungDepartment of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, BandungDepartment of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, BandungObjective: To present a case of high-risk, stage four neuroblastoma in a 20-year-old woman who survived more than 21 months with the multimodal therapy. Methods: A case of high-risk, stage four neuroblastoma in a 20-year-old woman who survived more than 21 months with multimodal therapy is reported. The patient initially received neoadjuvant chemotherapy according to the Turkish Pediatric Oncology Group of Neuroblastoma, along with multiple doses of radiotherapy. After two cycles of induction chemotherapy, she successfully underwent tumor debulking surgery. Results: With the multimodal therapy, patient remains in complete remission state and stable disease of the remaining lesions is observed in this patient. Conclusions: Neuroblastoma is a rare disease in adults and associated with a high number of mortality. Early and accurate diagnosis and multimodality of treatments are important to achieve disease control. Long term follow up is necessary for such patients.https://journal.fk.unpad.ac.id/index.php/ijihs/article/view/2868high-risk neuroblastomalong term survivalyoung adult. |
| spellingShingle | Amaylia Oehadian Afiati Afiati Martina Sung Kevin Yonatan Budiman Fransisca Fransisca High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case Report International Journal of Integrated Health Sciences high-risk neuroblastoma long term survival young adult. |
| title | High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case Report |
| title_full | High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case Report |
| title_fullStr | High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case Report |
| title_full_unstemmed | High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case Report |
| title_short | High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case Report |
| title_sort | high risk neuroblastoma in young adult and long term survival with multimodal therapy a case report |
| topic | high-risk neuroblastoma long term survival young adult. |
| url | https://journal.fk.unpad.ac.id/index.php/ijihs/article/view/2868 |
| work_keys_str_mv | AT amayliaoehadian highriskneuroblastomainyoungadultandlongtermsurvivalwithmultimodaltherapyacasereport AT afiatiafiati highriskneuroblastomainyoungadultandlongtermsurvivalwithmultimodaltherapyacasereport AT martinasung highriskneuroblastomainyoungadultandlongtermsurvivalwithmultimodaltherapyacasereport AT kevinyonatanbudiman highriskneuroblastomainyoungadultandlongtermsurvivalwithmultimodaltherapyacasereport AT fransiscafransisca highriskneuroblastomainyoungadultandlongtermsurvivalwithmultimodaltherapyacasereport |